ArriVent BioPharma, Inc. Common Stock
ArriVent BioPharma, Inc. Common Stock（AVBP）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
avbp · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$45.00
Consensus
$45.00
+47.4% upside
Low
$45.00
Median: $45 · Last Close: $30.54
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $32.06 | ↑ 5.00% |
1-day model range: $31.83–$32.3. Peak: $32.3 (+5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $35 | +15.3% |
| 2028 | $38 | +25.0% |
| 2029 | $40 | +30.7% |
| 2030 | $41 | +34.1% |
| 2031 | — | +35.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AVBP · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-29 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-13 | Citigroup | Maintains | Buy→Buy |
| 2026-04-24 | Citigroup | Maintains | Buy→Buy |
| 2026-03-23 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-06 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-06 | Citigroup | Maintains | Buy→Buy |
| 2025-11-11 | Citigroup | Maintains | Buy→Buy |
| 2025-08-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-12 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ArriVent BioPharma, Inc. Common Stock (AVBP) stock. Of the recent 25 rating actions, 0 were upgrades and 0 were downgrades. 7 analysts currently cover AVBP.
分析师推荐趋势
AVBP analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.9% YoY
Revenue Next Year
$44M
↑ 34804.7% YoY
EPS This Year
$-4.00
EPS Next Year
$-3.42
↓ 14.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVBP EPS of $-4.00 for the current fiscal year, based on estimates from 8 analysts. The AVBP revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AVBP 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AVBP 的共识目标价为 $45.00（+47.4% 上行空间），分析师共识为 Buy。
AVBP 的短期预测（明日）为 $32.06（+5.00%）。 AVBP 对 2027 年的股价预测均值为 $35。 AVBP 对 2030 年的预测区间为 $38–$44。
ArriVent BioPharma, Inc. Common Stock 在 NASDAQ 上市，代码 AVBP。AVBP 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
AVBP 预测 · 8 个问题根据 7 位华尔街分析师，AVBP 的 12 个月平均目标价为 $45.00，最高 $45.00、最低 $45.00。若有图表，中位目标价可在上方查看。相对当前价 $30.54，隐含约 +47.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.